However, subanalysis excluding diffuse-type cancers revealed that the percentage of CD8+/CD3+ cells was significantly higher in GC-peri-tumor samples than in GC-body samples (Figure 8 in Appendices). The gene discussed is CD8A; the disease is neoplasm.